Published on 18th December 2012
Pharmaceutical companies GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for UMEC/VI medicine, used to treat chronic obstructive pulmonary disease (COPD).
URL: http://www.digitallook.com/dl/news/story/20574407/...